Allocate Software PLC Acquisition of RealTime Health (8604I)
31 July 2012 - 4:01PM
UK Regulatory
TIDMALL
RNS Number : 8604I
Allocate Software PLC
31 July 2012
31 July 2012
ALLOCATE SOFTWARE PLC
("Allocate" or "the Company")
Acquisition of RealTime Health
Allocate Software, (AIM: ALL), the leading provider of workforce
optimisation and corporate governance, risk & compliance
software, has acquired RealTime Health Limited ("RealTime Health"
or the "Company") for an initial cash consideration of GBP1.2
million from its founders and management.
RealTime Health's Patient Flow software optimises the use of
beds in hospitals, tracking a patient's progress towards a planned
discharge date. It is designed to reduce a patient's length of
stay, where possible, thereby allowing Trusts to improve staffing
efficiency by enabling them to care for a greater number of
patients with the same level of resources. This in turn provides
the opportunity to realise material cost savings, without
compromising patient care.
Overview of RealTime Health and the Acquisition
-- RealTime Health is the award winning provider of Patient Flow
software to hospitals in the UK. Patient Flow is an emerging,
rapidly growing market opportunity
-- With RealTime Health solutions, hospitals are able to both
improve their clinical processes and to optimise the use of their
resources
-- RealTime Health has an installed base of 8 NHS Trusts
-- Unaudited management accounts for the year ended 31 December
2011, reported c. GBP0.7 million in billings and in the 6 months to
30 June 2012 show a further GBP0.6 million of billings
-- The software is deployed at customer sites. It will be
licenced on an annual, recurring basis
-- RealTime Health employs 13 staff, including the founding
management team, who are based in Oxford and who will be remaining
with the business
-- The maximum total consideration, based on zero net assets, of
up to GBP7.2 million is structured as an initial payment of GBP1.2
million and an earn-out of up to GBP6.0 million in tranches
- The initial cash payment of GBP1.2 million will be paid from
existing cash resources. The deferred cash payments of up to a
maximum of GBP6.0 million are based upon the meeting of conditions,
including achieving a number of demanding billings targets, which
will require a high rate of new customer acquisition during the 24
months following completion.
-- The acquisition is expected to be slightly EBITDA negative in
the first year of ownership, turning positive during the
second.
Ian Bowles, CEO of Allocate commented: "We are delighted to have
concluded the acquisition of RealTime Health. We see a very
significant market opportunity from the integration of their
applications into our broader portfolio within the HealthSuite. The
integration of the applications combined with the strong ROI will
deliver a compelling and unique solution for our customers, in what
is a largely unpenetrated and emerging area of focus for NHS
Trusts. The combination of Allocate and RealTime Health provides
the opportunity of matching patient demand, clinical activity
management and staff deployment, which will drive significant
efficiencies and cost savings. The RealTime Health executives and
staff, with their domain expertise are a very welcome addition to
the Allocate Team. I look forward to working with them to deliver
the vision we share in bringing our combined solutions to
customers."
Commenting on the acquisition, Jim Gabriel, CEO of RealTime
Health said: "Since 2008 we have been helping hospitals reduce
in-patient length of stay and in doing so we have been helping to
create significant cost savings for Trusts in the UK. We are
excited to be combining forces with Allocate in order to take the
RealTime Health solution to a much broader market."
RealTime Health
RealTime Health was officially founded in 2008 by Dr Jess Boyer,
who initially developed the best practice methodologies for care
pathways whilst providing consultancy to US hospitals.
The RealTime Health Patient Flow application provides a 'live'
status report on all available beds, patient tracking and discharge
planning. It is used by operational, administrative, clinical and
medical staff - particularly consultants, doctors and nurses.
The application also has infection control capability and is
used to track those beds that have been used by patients with a
hospital acquired infection. This provides the real time ability to
track other patients who may have been exposed to the same
infection and to mitigate the risk of further spreading of an
infection.
Enquiries:
Allocate Software plc Tel: +44 (0) 20 7355 5555
Ian Bowles - Chief Executive Officer
Chris Gale - Chief Financial Officer
Strata Partners (Financial Adviser) Tel: +44 (0) 20 7730 1200
Edward Roskill
Alistair Armstrong-Brown
Numis Securities Limited (NOMAD / Corporate
Broker) Tel: +44 (0) 20 7260 1000
Nominated adviser - Michael Meade /
Simon Willis /
Richard Thomas
Corporate Broking - James Black
Gable Communications Tel: +44 (0) 20 7193 7463
Justine James +44 (0) 7525 324 431
John Bick
About Allocate Software plc
Allocate Software plc is the leading workforce and compliance
optimisation software applications provider for world-wide
organisations with large, multi-skilled workforces. With a blue
chip client base spanning the public and private sector, its key
vertical markets include: Healthcare and Defence.
At the core of the business is Allocate's workforce optimisation
software, which organisations use to deploy the right people with
the right skills, to the right place at the right time.
Headquartered in London, Allocate provides services and support to
its increasing international customer base through regional offices
in the UK, Sweden, USA, Australia and Malaysia.
Allocate is quoted on the London Stock Exchange (AIM: ALL). For
further information please visit www.Allocatesoftware.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACQFMGFNLGLGZZM
Atlantic Lithium (LSE:ALL)
Historical Stock Chart
From Jan 2025 to Feb 2025
Atlantic Lithium (LSE:ALL)
Historical Stock Chart
From Feb 2024 to Feb 2025